Please login to the form below

Not currently logged in


This page shows the latest Zeposia news and features for those working in and with pharma, biotech and healthcare.

BMS’ Zeposia gains FDA approval in ulcerative colitis

BMS’ Zeposia gains FDA approval in ulcerative colitis

During maintenance at week 52, Zeposia also improved clinical remission and met the same key secondary endpoints as listed above. ... Zeposia combines disease control through lasting remission and demonstrated safety in a once-daily pill,” he added.

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....